ST. LOUIS — All morning, nurses had been coming in, taking vitals, offering blankets, pressing buttons to silence alarms. It ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, ...

The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode ...

Genetic screening is crucial in identifying potential genetic disorders, enabling couples to make informed decisions about ...

THE United States has reaffirmed its commitment to supporting Tanzania in the fight against sickle cell disease with focus on ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

Participants at the launch of National Sickle Cell Disease Strategy and National Vaccine Policy The Ministry Of Health has ...

Beam Therapeutics' early clinical data shows promising results for sickle cell disease treatment using CRISPR gene editing tool. One patient died ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

An ultra-modern Higher Education Centre of Excellence (ACE) was officially inaugurated on Friday, November 8, at the ...

In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...